{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:52:10Z","timestamp":1761709930187,"version":"build-2065373602"},"reference-count":207,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002635","82002636","82173593"],"award-info":[{"award-number":["82002635","82002636","82173593"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M682668","2020T130132"],"award-info":[{"award-number":["2020M682668","2020T130132"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["202102020421"],"award-info":[{"award-number":["202102020421"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.bbcan.2022.188691","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T09:52:07Z","timestamp":1643795527000},"page":"188691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["The role of m6A modification in pediatric cancer"],"prefix":"10.1016","volume":"1877","author":[{"given":"Yongping","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiran","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenjian","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"38","key":"10.1016\/j.bbcan.2022.188691_bb0005","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1038\/sj.onc.1207717","article-title":"Epidemiology and genetics of childhood cancer","volume":"23","author":"Stiller","year":"2004","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0010","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10555-019-09836-y","article-title":"Compare and contrast: pediatric cancer versus adult malignancies","volume":"38","author":"Kattner","year":"2019","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.sempedsurg.2019.150864","article-title":"Pediatric surgical oncology: a brief overview of where we have been and the challenges we face","volume":"28","author":"von Allmen","year":"2019","journal-title":"Semin. Pediatr. Surg."},{"issue":"13","key":"10.1016\/j.bbcan.2022.188691_bb0020","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/cncr.32885","article-title":"Long-term causes of death among pediatric patients with cancer","volume":"126","author":"Horn","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2022.188691_bb0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41568-019-0169-x","article-title":"Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours","volume":"19","author":"Jones","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.sempedsurg.2016.10.003","article-title":"Complications in the surgical management of children with malignant solid tumors","volume":"25","author":"Davidoff","year":"2016","journal-title":"Semin. Pediatr. Surg."},{"issue":"10","key":"10.1016\/j.bbcan.2022.188691_bb0035","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"46","key":"10.1016\/j.bbcan.2022.188691_bb0040","doi-asserted-by":"crossref","first-page":"15170","DOI":"10.1523\/JNEUROSCI.3236-14.2014","article-title":"Novel RNA modifications in the nervous system: form and function","volume":"34","author":"Satterlee","year":"2014","journal-title":"the journal of neuroscience : the official journal of the society forNeuroscience"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0045","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.bbcan.2022.188691_bb0055","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.tig.2016.09.006","article-title":"Update: mechanisms underlying N(6)-methyladenosine modification of Eukaryotic mRNA","volume":"32","author":"Wang","year":"2016","journal-title":"Trends Genetics"},{"issue":"7","key":"10.1016\/j.bbcan.2022.188691_bb0060","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0065","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.molcel.2019.04.025","article-title":"Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers","volume":"74","author":"Shi","year":"2019","journal-title":"Mol. Cell"},{"issue":"7695","key":"10.1016\/j.bbcan.2022.188691_bb0070","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature25784","article-title":"The SMAD2\/3 interactome reveals that TGF\u03b2 controls m(6)A mRNA methylation in pluripotency","volume":"555","author":"Bertero","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0075","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41556-019-0318-1","article-title":"Stage-specific requirement for Mettl3-dependent m(6)A mRNA methylation during haematopoietic stem cell differentiation","volume":"21","author":"Lee","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"7724","key":"10.1016\/j.bbcan.2022.188691_bb0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-018-0538-8","article-title":"mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis","volume":"561","author":"Choe","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bbcan.2022.188691_bb0085","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0090","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"issue":"9","key":"10.1016\/j.bbcan.2022.188691_bb0095","first-page":"4456","article-title":"N6-methyladenosine residues in an intron-specific region of prolactin pre-mRNA","volume":"10","author":"Carroll","year":"1990","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0100","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1128\/jvi.42.3.918-931.1982","article-title":"Accumulation of spliced avian retrovirus mRNA is inhibited in S-adenosylmethionine-depleted chicken embryo fibroblasts","volume":"42","author":"Stoltzfus","year":"1982","journal-title":"J. Virol."},{"key":"10.1016\/j.bbcan.2022.188691_bb0105","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking m(6)A readers, writers, and erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrg3724","article-title":"Gene expression regulation mediated through reversible m6A RNA methylation","volume":"15","author":"Fu","year":"2014","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa225","article-title":"Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma","volume":"22","author":"Li","year":"2021","journal-title":"Brief. Bioinform."},{"issue":"11","key":"10.1016\/j.bbcan.2022.188691_bb0120","first-page":"1233","article-title":"Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase","volume":"3","author":"Bokar","year":"1997","journal-title":"RNA (New York, N.Y.)"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ncb2902","article-title":"N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells","volume":"16","author":"Wang","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0135","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/cr.2014.3","article-title":"Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase","volume":"24","author":"Ping","year":"2014","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41419-017-0129-x","article-title":"N6-methyladenosine links RNA metabolism to cancer progression","volume":"9","author":"Dai","year":"2018","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0145","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","article-title":"RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1-mTORC1 Axis and is a therapeutic target","volume":"160","author":"Chen","year":"2021","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.bbcan.2022.188691_bb0150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"issue":"25","key":"10.1016\/j.bbcan.2022.188691_bb0155","doi-asserted-by":"crossref","first-page":"17299","DOI":"10.1074\/jbc.M114.550350","article-title":"Structures of human ALKBH5 demethylase reveal a unique binding mode for specific single-stranded N6-methyladenosine RNA demethylation","volume":"289","author":"Xu","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.bbcan.2022.188691_bb0160","doi-asserted-by":"crossref","first-page":"20734","DOI":"10.1074\/jbc.R115.656462","article-title":"The AlkB family of Fe(II)\/\u03b1-ketoglutarate-dependent dioxygenases: repairing nucleic acid alkylation damage and beyond","volume":"290","author":"Fedeles","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2022.188691_bb0165","first-page":"1","article-title":"FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway","author":"Zhang","year":"2020","journal-title":"RNA Biol."},{"issue":"7397","key":"10.1016\/j.bbcan.2022.188691_bb0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"issue":"7481","key":"10.1016\/j.bbcan.2022.188691_bb0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"issue":"7620","key":"10.1016\/j.bbcan.2022.188691_bb0180","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature19342","article-title":"m(6)A RNA methylation promotes XIST-mediated transcriptional repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbcan.2022.188691_bb0185","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/nchembio.1654","article-title":"Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain","volume":"10","author":"Xu","year":"2014","journal-title":"Nat. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0190","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0195","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","article-title":"YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis","volume":"38","author":"Chang","year":"2020","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m(6)A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0205","first-page":"1631","article-title":"METTL3 plays multiple functions in biological processes","volume":"10","author":"Liu","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0210","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/cr.2017.31","article-title":"Extensive translation of circular RNAs driven by N(6)-methyladenosine","volume":"27","author":"Yang","year":"2017","journal-title":"Cell Res."},{"issue":"5507","key":"10.1016\/j.bbcan.2022.188691_bb0215","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding RNA networks in cancer","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0225","first-page":"310","article-title":"m6A modification of non-coding RNA and the control of mammalian gene expression, biochimica et biophysica acta","volume":"1862","author":"Coker","year":"2019","journal-title":"Gene Regulatory Mechanisms"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","article-title":"RNA in cancer","volume":"21","author":"Goodall","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2022.188691_bb0235","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0240","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of long noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12929-019-0523-z","article-title":"The emerging roles and functions of circular RNAs and their generation","volume":"26","author":"Yu","year":"2019","journal-title":"J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0250","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12943-018-0827-8","article-title":"Circular RNAs function as ceRNAs to regulate and control human cancer progression","volume":"17","author":"Zhong","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12943-020-1146-4","article-title":"METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST","volume":"19","author":"Yang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-020-01293-4","article-title":"Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine","volume":"19","author":"Wen","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0265","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13045-019-0839-x","article-title":"M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma","volume":"13","author":"Zuo","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"suppl_5","key":"10.1016\/j.bbcan.2022.188691_bb0270","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014","volume":"19","author":"Ostrom","year":"2017","journal-title":"Neuro-oncology"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0275","doi-asserted-by":"crossref","first-page":"863","DOI":"10.21037\/apm-20-640","article-title":"Overview of prognostic factors in adult gliomas","volume":"10","author":"Sharma","year":"2021","journal-title":"Annals of Palliative Medicine"},{"key":"10.1016\/j.bbcan.2022.188691_bb0280","first-page":"15017","article-title":"Glioma","volume":"1","author":"Weller","year":"2015","journal-title":"Nature Reviews"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0285","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1634\/theoncologist.9-2-197","article-title":"Supratentorial high-grade astrocytoma and diffuse brainstem glioma: two challenges for the pediatric oncologist","volume":"9","author":"Broniscer","year":"2004","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0290","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.soncn.2018.10.001","article-title":"Epidemiology and overview of gliomas","volume":"34","author":"Davis","year":"2018","journal-title":"Semin. Oncol. Nurs."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0295","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ncl.2016.06.014","article-title":"Epidemiology of brain tumors","volume":"34","author":"McNeill","year":"2016","journal-title":"Neurol. Clin."},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0300","first-page":"750","article-title":"Pediatric low-grade gliomas: implications of the biologic era","volume":"19","author":"Packer","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0305","first-page":"294","article-title":"Pediatric low-grade gliomas: how modern biology reshapes the clinical field","volume":"1845","author":"Bergthold","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bbcan.2022.188691_bb0310","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/pbc.24958","article-title":"Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the surveillance epidemiology and end results (SEER) database","volume":"61","author":"Bandopadhayay","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"issue":"7 Suppl","key":"10.1016\/j.bbcan.2022.188691_bb0315","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/cncr.23741","article-title":"Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium","volume":"113","author":"Bondy","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0320","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11910-007-0032-4","article-title":"Environmental risk factors for brain tumors","volume":"7","author":"Connelly","year":"2007","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11910-011-0189-8","article-title":"Current state of our knowledge on brain tumor epidemiology","volume":"11","author":"Ostrom","year":"2011","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0330","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11060-017-2393-0","article-title":"Pediatric high-grade glioma: current molecular landscape and therapeutic approaches","volume":"134","author":"Braunstein","year":"2017","journal-title":"J. Neuro-Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0335","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11940-996-0003-0","article-title":"Primary central nervous system tumors in children","volume":"1","author":"Packer","year":"1999","journal-title":"Curr. Treat. Options Neurol."},{"issue":"22","key":"10.1016\/j.bbcan.2022.188691_bb0340","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM199412013312207","article-title":"Brain tumors in children","volume":"331","author":"Pollack","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"40","key":"10.1016\/j.bbcan.2022.188691_bb0345","doi-asserted-by":"crossref","first-page":"65696","DOI":"10.18632\/oncotarget.11602","article-title":"Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma","volume":"7","author":"Koschmann","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0350","first-page":"153","article-title":"Pediatric high-grade glioma: biologically and clinically in need of new thinking","volume":"19","author":"Jones","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2022.188691_bb0355","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bbcan.2022.188691_bb0360","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/cas.12022","article-title":"Expression and roles of Wilms' tumor 1-associating protein in glioblastoma","volume":"103","author":"Jin","year":"2012","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0365","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12031-016-0788-6","article-title":"WTAP expression predicts poor prognosis in malignant glioma patients","volume":"60","author":"Xi","year":"2016","journal-title":"Journal of Molecular Neuroscience : MN"},{"issue":"11","key":"10.1016\/j.bbcan.2022.188691_bb0370","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","article-title":"m(6)A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells","volume":"18","author":"Cui","year":"2017","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0375","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000499062","article-title":"m6A RNA methylation controls proliferation of human glioma cells by influencing cell apoptosis","volume":"159","author":"Li","year":"2019","journal-title":"Cytogenet. Genome Res."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0380","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/2159-8290.CD-20-0331","article-title":"The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells","volume":"11","author":"Dixit","year":"2021","journal-title":"Cancer Discovery"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0385","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1080\/21655979.2021.2018386","article-title":"N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner","volume":"13","author":"Miao","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0390","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41467-020-20379-7","article-title":"EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma","volume":"12","author":"Fang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2022.188691_bb0395","article-title":"Prognosis analysis and validation of m(6)A signature and tumor immune microenvironment in glioma","volume":"10","author":"Lin","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0400","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","article-title":"m(6)A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustainingFOXM1 expression and cell proliferation program","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"issue":"6409","key":"10.1016\/j.bbcan.2022.188691_bb0405","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.aau1646","article-title":"RNA modifications modulate gene expression during development","volume":"361","author":"Frye","year":"2018","journal-title":"Science (New York, N.Y.)"},{"issue":"18","key":"10.1016\/j.bbcan.2022.188691_bb0410","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","article-title":"FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a cluster-MXI1 feedback circuit in glioma","volume":"80","author":"Xiao","year":"2020","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bbcan.2022.188691_bb0415","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discovery"},{"issue":"11","key":"10.1016\/j.bbcan.2022.188691_bb0420","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1111\/cas.15072","article-title":"Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells","volume":"112","author":"Li","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2022.188691_bb0425","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.canlet.2021.04.020","article-title":"METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-\u03baB to promote the malignant progression of IDH-wildtype glioma","volume":"511","author":"Chang","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0430","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13045-019-0830-6","article-title":"m(6)A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis","volume":"12","author":"Jin","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0435","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009086","article-title":"miRNA-mediated loss of m6A increases nascent translation in glioblastoma","volume":"17","author":"Zepecki","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbcan.2022.188691_bb0440","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3389\/fcell.2020.00642","article-title":"N6-methylandenosine-related lncRNAs are potential biomarkers for predicting the overall survival of lower-grade glioma patients","volume":"8","author":"Tu","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"13","key":"10.1016\/j.bbcan.2022.188691_bb0445","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1111\/jcmm.15382","article-title":"Prognostic values of YTHDF1 regulated negatively by mir-3436 in glioma","volume":"24","author":"Xu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/genes10020141","article-title":"N6-methyladenosine landscape of glioma stem-like cells: METTL3 is essential for the expression of actively transcribed genes and sustenance of the oncogenic signaling","volume":"10","author":"Visvanathan","year":"2019","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0455","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10143-020-01238-x","article-title":"Identification of N(6)-methyladenosine-related lncRNAs for patients with primary glioblastoma","volume":"44","author":"Wang","year":"2021","journal-title":"Neurosurg. Rev."},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0460","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/pbc.24215","article-title":"The epidemiology of hepatoblastoma","volume":"59","author":"Spector","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"20","key":"10.1016\/j.bbcan.2022.188691_bb0465","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/jnci\/80.20.1626","article-title":"Hepatoblastoma and familial adenomatous polyposis","volume":"80","author":"Garber","year":"1988","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0470","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10024-005-1154-9","article-title":"Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives","volume":"8","author":"Cohen","year":"2005","journal-title":"Pediatric and Developmental Pathology"},{"issue":"15","key":"10.1016\/j.bbcan.2022.188691_bb0475","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/S0959-8049(03)00618-X","article-title":"Familial hepatoblastoma and APC gene mutations: renewed call for molecular research","volume":"39","author":"Thomas","year":"2003","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0480","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00247-005-0064-3","article-title":"Hepatoblastoma: an oncological review","volume":"36","author":"Roebuck","year":"2006","journal-title":"Pediatr. Radiol."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0485","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0b013e3181ce5f1e","article-title":"Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study","volume":"34","author":"Wang","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"issue":"20","key":"10.1016\/j.bbcan.2022.188691_bb0490","doi-asserted-by":"crossref","first-page":"555","DOI":"10.21037\/atm.2019.09.76","article-title":"Survival and analysis of prognostic factors for hepatoblastoma: based on SEER database","volume":"7","author":"Feng","year":"2019","journal-title":"Ann Transl Med"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0495","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12768","article-title":"Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt\/\u03b2-catenin signalling pathway","volume":"53","author":"Cui","year":"2020","journal-title":"Cell Prolif."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0500","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12943-019-1119-7","article-title":"m(6)A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/MOP.0000000000000046","article-title":"Hepatoblastoma state of the art: pathology, genetics, risk stratification, and chemotherapy","volume":"26","author":"Czauderna","year":"2014","journal-title":"Curr. Opin. Pediatr."},{"issue":"11","key":"10.1016\/j.bbcan.2022.188691_bb0510","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3249","article-title":"YTHDC1 gene polymorphisms and hepatoblastoma susceptibility in chinese children: a seven-center case-control study","volume":"22","author":"Chen","year":"2020","journal-title":"Journal of Gene Medicine"},{"key":"10.1016\/j.bbcan.2022.188691_bb0515","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.omto.2020.06.007","article-title":"WTAP gene variants confer hepatoblastoma susceptibility: a seven-center case-control study","volume":"18","author":"Zhuo","year":"2020","journal-title":"Molecular Therapy Oncolytics"},{"issue":"17","key":"10.1016\/j.bbcan.2022.188691_bb0520","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.7150\/jca.46120","article-title":"YTHDF1 rs6090311 A>G polymorphism reduces hepatoblastoma risk: evidence from a seven-center case-control study","volume":"11","author":"Luo","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2022.188691_bb0525","doi-asserted-by":"crossref","first-page":"6658480","DOI":"10.1155\/2021\/6658480","article-title":"ALKBH5 gene polymorphisms and hepatoblastoma susceptibility in chinese children","volume":"2021","author":"Ren","year":"2021","journal-title":"J.Oncol."},{"key":"10.1016\/j.bbcan.2022.188691_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145834","article-title":"Polymorphisms in METTL3 gene and hepatoblastoma risk in chinese children: a seven-center case-control study","volume":"800","author":"Chen","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.bbcan.2022.188691_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.146050","article-title":"METTL14 gene polymorphisms influence hepatoblastoma predisposition in chinese children: evidences from a seven-center case-control study","volume":"809","author":"Chen","year":"2022","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0540","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/mpo.2950210305","article-title":"Epidemiology of wilms tumor","volume":"21","author":"Breslow","year":"1993","journal-title":"Med. Pediatr. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0545","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pbc.24419","article-title":"Children's oncology Group's 2013 blueprint for research: renal tumors","volume":"60","author":"Dome","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0550","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-3016.2010.01133.x","article-title":"Wilms' tumour: a systematic review of risk factors and meta-analysis","volume":"24","author":"Chu","year":"2010","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0555","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41581-019-0112-0","article-title":"The genetic changes of wilms tumour","volume":"15","author":"Treger","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0560","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.yapd.2012.04.001","article-title":"Wilms tumor","volume":"59","author":"Davidoff","year":"2012","journal-title":"Adv. Pediatr."},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0565","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/bjc.1990.432","article-title":"International variations in the incidence of childhood renal tumours","volume":"62","author":"Stiller","year":"1990","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0570","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/(SICI)1096-911X(199611)27:5<398::AID-MPO2>3.0.CO;2-H","article-title":"Familial Wilms' tumor: a descriptive study","volume":"27","author":"Breslow","year":"1996","journal-title":"Med. Pediatr. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2022.188691_bb0575","first-page":"1387","article-title":"Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors","volume":"58","author":"McDonald","year":"1998","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0580","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/ng0896-461","article-title":"Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21","volume":"13","author":"Rahman","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2022.188691_bb0585","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jss.2019.10.044","article-title":"Global disparities in wilms tumor","volume":"247","author":"Cunningham","year":"2020","journal-title":"J. Surg. Res."},{"issue":"9407","key":"10.1016\/j.bbcan.2022.188691_bb0590","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(04)15491-3","article-title":"Epigenetic differences between Wilms' tumours in white and east-asian children","volume":"363","author":"Fukuzawa","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"13","key":"10.1016\/j.bbcan.2022.188691_bb0595","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.ejca.2006.05.010","article-title":"Malignant renal tumours incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project","volume":"42","author":"Pastore","year":"2006","journal-title":"European journal of cancer (Oxford, England : 1990)"},{"issue":"9","key":"10.1016\/j.bbcan.2022.188691_bb0600","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrc1696","article-title":"Wilms' tumour: connecting tumorigenesis and organ development in the kidney","volume":"5","author":"Rivera","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"1\u20132","key":"10.1016\/j.bbcan.2022.188691_bb0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15513819009067094","article-title":"Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor","volume":"10","author":"Beckwith","year":"1990","journal-title":"Pediatr. Pathol."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0610","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/pbc.20891","article-title":"Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of wilms tumor","volume":"47","author":"Breslow","year":"2006","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.bbcan.2022.188691_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144839","article-title":"The contribution of WTAP gene variants to wilms tumor susceptibility","volume":"754","author":"Ma","year":"2020","journal-title":"Gene"},{"issue":"11","key":"10.1016\/j.bbcan.2022.188691_bb0620","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3255","article-title":"METTL3 polymorphisms and wilms tumor susceptibility in chinese children: a five-center case-control study","volume":"22","author":"Lin","year":"2020","journal-title":"Journal of Gene Medicine"},{"key":"10.1016\/j.bbcan.2022.188691_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145571","article-title":"YTHDC1 gene polymorphisms and wilms tumor susceptibility in chinese children: a five-center case-control study","volume":"783","author":"Lin","year":"2021","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0630","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23251","article-title":"ALKBH5 gene polymorphisms and wilms tumor risk in chinese children: a five-center case-control study","volume":"34","author":"Hua","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bbcan.2022.188691_bb0635","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3348","article-title":"Role of FTO gene polymorphisms in Wilms tumor predisposition: a five-center case-control study","author":"Hua","year":"2021","journal-title":"Journal of Gene Medicine"},{"key":"10.1016\/j.bbcan.2022.188691_bb0640","first-page":"16078","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nature Reviews"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0645","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00441-018-2796-z","article-title":"Origin and initiation mechanisms of neuroblastoma","volume":"372","author":"Tsubota","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0650","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.2910520407","article-title":"International variations in the incidence of neuroblastoma","volume":"52","author":"Stiller","year":"1992","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0655","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-3016.2008.00983.x","article-title":"The epidemiology of neuroblastoma: a review","volume":"23","author":"Heck","year":"2009","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0660","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pcl.2014.09.015","article-title":"Neuroblastoma: paradigm for precision medicine","volume":"62","author":"Irwin","year":"2015","journal-title":"Pediatr. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0665","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1200\/JCO.2010.29.6103","article-title":"Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's oncology group study","volume":"29","author":"Henderson","year":"2011","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0670","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/14737140.2017.1285230","article-title":"Overview and recent advances in the treatment of neuroblastoma","volume":"17","author":"Whittle","year":"2017","journal-title":"Expert. Rev. Anticancer. Ther."},{"issue":"16","key":"10.1016\/j.bbcan.2022.188691_bb0675","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1111\/jcmm.15576","article-title":"Association between METTL3 gene polymorphisms and neuroblastoma susceptibility: a nine-Centre case-control study","volume":"24","author":"Bian","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2022.188691_bb0680","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.omtn.2020.08.009","article-title":"METTL14 gene polymorphisms confer neuroblastoma susceptibility: an eight-center case-control study","volume":"22","author":"Zhuo","year":"2020","journal-title":"Molecular Therapy. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0685","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3233\/CBM-191196","article-title":"A five-gene signature derived from m6A regulators to improve prognosis prediction of neuroblastoma","volume":"28","author":"Wang","year":"2020","journal-title":"Cancer Biomarkers"},{"issue":"8","key":"10.1016\/j.bbcan.2022.188691_bb0690","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.7150\/jca.54496","article-title":"YTHDF1 gene polymorphisms and neuroblastoma susceptibility in chinese children: an eight-center case-control study","volume":"12","author":"Liu","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0695","doi-asserted-by":"crossref","first-page":"146","DOI":"10.21037\/tp-20-168","article-title":"Associations between WTAP gene polymorphisms and neuroblastoma susceptibility in chinese children","volume":"10","author":"Tang","year":"2021","journal-title":"Translational Pediatrics"},{"issue":"23","key":"10.1016\/j.bbcan.2022.188691_bb0700","doi-asserted-by":"crossref","first-page":"25426","DOI":"10.18632\/aging.203760","article-title":"YTHDC1 gene polymorphisms and neuroblastoma susceptibility in chinese children","volume":"13","author":"Li","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.bbcan.2022.188691_bb0705","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.797195","article-title":"YTHDF2 gene rs3738067 A>G polymorphism decreases neuroblastoma risk in chinese children: evidence from an eight-center case-control study","volume":"8","author":"Zeng","year":"2021","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0710","doi-asserted-by":"crossref","first-page":"13624","DOI":"10.1038\/s41598-020-64682-1","article-title":"RNA N(6)-methyladenosine modification is required for miR-98\/MYCN axis-mediated inhibition of neuroblastoma progression","volume":"10","author":"Cheng","year":"2020","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bbcan.2022.188691_bb0715","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nrc3838","article-title":"Translational biology of osteosarcoma","volume":"14","author":"Kansara","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0720","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40744-016-0046-y","article-title":"Review of osteosarcoma and current management","volume":"3","author":"Durfee","year":"2016","journal-title":"Rheumatology and Therapy"},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0725","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.canep.2015.05.001","article-title":"Prognostic factors for survival in patients with high-grade osteosarcoma using the surveillance, epidemiology, and end results (SEER) program database","volume":"39","author":"Duchman","year":"2015","journal-title":"Cancer Epidemiol."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0730","first-page":"59","article-title":"Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999\u20132008","volume":"40","author":"Duong","year":"2013","journal-title":"J. Registry Manag."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0735","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pbiomolbio.2016.01.005","article-title":"Epigenetic mechanisms of bone regeneration and homeostasis","volume":"122","author":"Liu","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"7","key":"10.1016\/j.bbcan.2022.188691_bb0740","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0745","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/cancers5020591","article-title":"Current therapeutic strategies and novel approaches in osteosarcoma","volume":"5","author":"Ando","year":"2013","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0750","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.ctrv.2013.11.006","article-title":"Osteosarcoma treatment - where do we stand? A state of the art review","volume":"40","author":"Luetke","year":"2014","journal-title":"Cancer Treat. Reviews"},{"key":"10.1016\/j.bbcan.2022.188691_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109627","article-title":"Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma","volume":"121","author":"Wang","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.bbcan.2022.188691_bb0760","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-319-07323-1_4","article-title":"Osteosarcoma","volume":"162","author":"Moore","year":"2014","journal-title":"Cancer Treat. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0765","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13018-021-02422-5","article-title":"Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value","volume":"16","author":"Liu","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.bbcan.2022.188691_bb0770","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.omtn.2021.12.008","article-title":"Analysis and identification of m(6)A RNA methylation regulators in metastatic osteosarcoma","volume":"27","author":"Huang","year":"2022","journal-title":"Molecular Therapy. Nucleic Acids"},{"issue":"15","key":"10.1016\/j.bbcan.2022.188691_bb0775","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2217\/epi-2019-0262","article-title":"Integrated analysis of transcriptome-wide m(6)A methylome of osteosarcoma stem cells enriched by chemotherapy","volume":"11","author":"Wang","year":"2019","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0780","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cell.2009.04.030","article-title":"WNT\/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis","volume":"138","author":"Nguyen","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0785","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bbrc.2019.06.128","article-title":"The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1","volume":"516","author":"Miao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2022.188691_bb0790","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3389\/fonc.2020.00769","article-title":"Dysregulated m6A-related regulators are associated with tumor metastasis and poor prognosis in osteosarcoma","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2022.188691_bb0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.109964","article-title":"Silencing METTL3 inhibits the proliferation and invasion of osteosarcoma by regulating ATAD2","volume":"125","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2022.188691_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102955","article-title":"N6-methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1","volume":"59","author":"Zhou","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2022.188691_bb0805","doi-asserted-by":"crossref","first-page":"12759","DOI":"10.2147\/CMAR.S284273","article-title":"METTL14 overexpression promotes osteosarcoma cell apoptosis and slows tumor progression via caspase 3 activation","volume":"12","author":"Liu","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"8","key":"10.1016\/j.bbcan.2022.188691_bb0810","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41419-020-02847-6","article-title":"WTAP promotes osteosarcoma tumorigenesis by repressing HMBOX1 expression in an m(6)A-dependent manner","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0815","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1186\/s12885-021-09011-z","article-title":"Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbcan.2022.188691_bb0820","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12935-020-1105-6","article-title":"ALKBH5-mediated m(6)A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0825","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200282","article-title":"m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma","volume":"40","author":"Ling","year":"2020","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0830","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41419-020-03315-x","article-title":"ALKBH5 suppresses tumor progression via an m(6)A-dependent epigenetic silencing of pre-miR-181b-1\/YAP signaling axis in osteosarcoma","volume":"12","author":"Yuan","year":"2021","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0835","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00335-021-09891-3","article-title":"Circular RNA circNRIP1 plays oncogenic roles in the progression of osteosarcoma","volume":"32","author":"Meng","year":"2021","journal-title":"Mamm. Genome"},{"issue":"suppl_5","key":"10.1016\/j.bbcan.2022.188691_bb0840","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro-oncology"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0845","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1215\/15228517-1-3-232","article-title":"Medulloblastoma: clinical and biologic aspects","volume":"1","author":"Packer","year":"1999","journal-title":"Neuro-Oncology"},{"issue":"12","key":"10.1016\/j.bbcan.2022.188691_bb0850","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S1474-4422(07)70289-2","article-title":"Medulloblastoma in childhood: new biological advances","volume":"6","author":"Crawford","year":"2007","journal-title":"Lancet. Neurology"},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0855","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-017-2594-6","article-title":"Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013","volume":"135","author":"Khanna","year":"2017","journal-title":"J. Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0860","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11060-014-1588-x","article-title":"Incidence of medulloblastoma in Canadian children","volume":"120","author":"Johnston","year":"2014","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0865","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11060-015-1979-7","article-title":"Pediatric brain tumors in a low\/middle income country: does it differ from that in developed world?","volume":"126","author":"Ezzat","year":"2016","journal-title":"J. Neuro-Oncol."},{"issue":"9","key":"10.1016\/j.bbcan.2022.188691_bb0870","first-page":"694","article-title":"Expression of heterogeneous nuclear ribonucleo-protein A2B1 in mouse cerebellar development and human medulloblastoma","volume":"48","author":"Zhao","year":"2019","journal-title":"Zhonghua bing li xue za zhi = Chinese journal of pathology"},{"key":"10.1016\/j.bbcan.2022.188691_bb0875","doi-asserted-by":"crossref","first-page":"15021","DOI":"10.1038\/nrdp.2015.21","article-title":"Retinoblastoma","volume":"1","author":"Dimaras","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bbcan.2022.188691_bb0880","first-page":"778","article-title":"Spectrum of germline RB1 mutations and clinical manifestations in retinoblastoma patients from Thailand","volume":"24","author":"Rojanaporn","year":"2018","journal-title":"Mol. Vis."},{"issue":"9","key":"10.1016\/j.bbcan.2022.188691_bb0885","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/bjo.2008.150292","article-title":"The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death","volume":"93","author":"Kivel\u00e4","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"3","key":"10.1016\/j.bbcan.2022.188691_bb0890","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3928\/01913913-20171116-03","article-title":"Retinoblastoma in the United States: a 40-year incidence and survival analysis","volume":"55","author":"Fernandes","year":"2018","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"issue":"12","key":"10.1016\/j.bbcan.2022.188691_bb0895","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12098-017-2395-0","article-title":"Retinoblastoma","volume":"84","author":"Rao","year":"2017","journal-title":"Indian J. Pediatr."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0900","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ijc.2910420408","article-title":"The international incidence of childhood cancer","volume":"42","author":"Parkin","year":"1988","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb0905","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.sjopt.2012.02.003","article-title":"\"Retinoblastoma survival disparity\": the expanding horizon in developing countries","volume":"26","author":"Naseripour","year":"2012","journal-title":"Saudi J. Ophthalmol."},{"issue":"3 Pt 1","key":"10.1016\/j.bbcan.2022.188691_bb0910","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-3476(98)70028-9","article-title":"Presenting signs of retinoblastoma","volume":"132","author":"Abramson","year":"1998","journal-title":"J. Pediatr."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0915","first-page":"431","article-title":"Differential diagnosis of leukocoria and strabismus, first presenting signs of retinoblastoma","volume":"1","author":"Balmer","year":"2007","journal-title":"Clin. Ophthalmol. (Auckland, N.Z.)"},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0920","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.bbcan.2022.188691_bb0925","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/s41433-019-0409-z","article-title":"Bilateral advanced (group D or E) intraocular retinoblastoma: outcomes in 72 asian indian patients","volume":"33","author":"Kaliki","year":"2019","journal-title":"Eye (London, England)"},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0930","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/ICU.0000000000000091","article-title":"Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy","volume":"25","author":"Shields","year":"2014","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"9","key":"10.1016\/j.bbcan.2022.188691_bb0935","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1136\/bjo.2008.148932","article-title":"Metastatic retinoblastoma: single institution experience over two decades","volume":"93","author":"Cozza","year":"2009","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb0940","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.arcped.2015.09.025","article-title":"Retinoblastoma update","volume":"23","author":"Aerts","year":"2016","journal-title":"Arch. Pediatrie"},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0945","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000509080","article-title":"Intravitreal melphalan for retinoblastoma: the impact of toxicity on recurrence and ultimate globe salvage","volume":"6","author":"Berry","year":"2020","journal-title":"Ocular Oncol. Pathol."},{"key":"10.1016\/j.bbcan.2022.188691_bb0950","doi-asserted-by":"crossref","first-page":"3638410","DOI":"10.1155\/2020\/3638410","article-title":"The role of intraarterial chemotherapy in the Management of Retinoblastoma","volume":"2020","author":"Pekacka","year":"2020","journal-title":"J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0955","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","article-title":"Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0960","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26931","article-title":"Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: a retrospective noncomparative single-institute experience","volume":"65","author":"Soliman","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"issue":"9","key":"10.1016\/j.bbcan.2022.188691_bb0965","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb0970","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1470-2045(18)30909-4","article-title":"Estimating the total incidence of global childhood cancer: a simulation-based analysis","volume":"20","author":"Ward","year":"2019","journal-title":"Lancet. Oncology"},{"issue":"9881","key":"10.1016\/j.bbcan.2022.188691_bb0975","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.bbcan.2022.188691_bb0980","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11864-016-0406-4","article-title":"CAR T cell therapy in acute lymphoblastic leukemia and potential for chronic lymphocytic leukemia","volume":"17","author":"Singh","year":"2016","journal-title":"Curr. Treat. Options in Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2022.188691_bb0985","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/S2352-3026(17)30052-2","article-title":"Worldwide comparison of survival from childhood leukaemia for 1995\u20132009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries","volume":"4","author":"Bonaventure","year":"2017","journal-title":"Lancet Haematol."},{"issue":"8","key":"10.1016\/j.bbcan.2022.188691_bb0990","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26532","article-title":"The global burden of childhood cancer: knowing what we do not know","volume":"64","author":"Frazier","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"issue":"20","key":"10.1016\/j.bbcan.2022.188691_bb0995","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.1182\/blood-2012-07-440107","article-title":"Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia","volume":"120","author":"Yang","year":"2012","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.bbcan.2022.188691_bb1000","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bbcan.2022.188691_bb1005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/aje\/kwaa215","article-title":"Trends in acute lymphoblastic leukemia incidence in the United States by Race\/Ethnicity from 2000 to 2016","volume":"190","author":"Feng","year":"2021","journal-title":"Am. J. Epidemiol."},{"issue":"10","key":"10.1016\/j.bbcan.2022.188691_bb1010","article-title":"The study of METTL3 and METTL14 expressions in childhood ETV6\/RUNX1-positive acute lymphoblastic leukemia","volume":"7","author":"Sun","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"issue":"2","key":"10.1016\/j.bbcan.2022.188691_bb1015","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1111\/ijlh.13386","article-title":"The gene expression level of m6A catalytic enzymes is increased in ETV6\/RUNX1-positive acute lymphoblastic leukemia","volume":"43","author":"Wang","year":"2021","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.bbcan.2022.188691_bb1020","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.2147\/CMAR.S335925","article-title":"Genetic variants in METTL14 are associated with the risk of acute lymphoblastic leukemia in southern chinese children: a five-center case-control study","volume":"13","author":"Luo","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.bbcan.2022.188691_bb1025","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mc.23330","article-title":"ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B","volume":"60","author":"Gong","year":"2021","journal-title":"Mol. Carcinog."},{"issue":"1","key":"10.1016\/j.bbcan.2022.188691_bb1030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cam4.3574","article-title":"N6-methyladenine-related genes affect biological behavior and the prognosis of glioma","volume":"10","author":"Qu","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2022.188691_bb1035","article-title":"M6A RNA methylation regulator HNRNPC contributes to tumorigenesis and predicts prognosis in glioblastoma multiforme","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X22000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X22000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:36:08Z","timestamp":1759638968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X22000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":207,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0304419X22000166"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2022.188691","relation":{},"ISSN":["0304-419X"],"issn-type":[{"type":"print","value":"0304-419X"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of m6A modification in pediatric cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2022.188691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"188691"}}